| Literature DB >> 12858134 |
Abstract
Migraine pain-relay centers, including the trigeminal ganglion, trigeminal nucleus caudalis, and thalamus, contain glutamate-positive neurons, and glutamate activates the trigeminal nucleus caudalis. Glutamate is implicated in cortical spreading depression, trigeminovascular activation, and central sensitization. Glutamate receptor-subtype antagonists are effective in preclinical models of migraine, and in the clinic. These preclinical and clinical observations argue for a strong link between migraine and the glutamatergic system, a link that is important to further characterize in an effort to better understand migraine mechanisms and deliver effective therapies.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12858134 DOI: 10.1017/s1092852900018757
Source DB: PubMed Journal: CNS Spectr ISSN: 1092-8529 Impact factor: 3.790